| ||
| Briefly: Factory orders post Oct. decline Memphis Commercial Appeal A former casino employee who said his lung cancer was caused by 25 years of exposure to secondhand smoke at work has settled a lawsuit against his ... See all stories on this topic » | ||
| FDA panel backs AZ's vandetanib for medullary thyroid cancer Pharma Times A final decision is due by January 7 for vandetanib, which was previously studied as a treatment for advanced non-small cell lung cancer in combination with ... See all stories on this topic » |
| ||
| US FDA Advisory Committee Makes Recommendation On New Drug ... By admin The safety profile of vandetanib in this study was similar to what has been previously observed in other studies of vandetanib in medullary thyroid and non- small cell lung cancer. Source: AstraZeneca ... Latest Health & Drugs News - http://news.drugs-expert.com/ | ||
| Wendy Harpham on Healthy Survivorship: How Rare is "Rare"? By Wendy Harpham For instance, relatively many people are diagnosed with small cell lung cancer ( SCLC). But because the disease is usually fatal fairly quickly, the population of SCLC survivors is small, i.e., the prevalance is low. ... Wendy Harpham on Healthy Survivorship - http://wendyharpham.typepad.com/healthy_survivorship/ |
| ||
| "???Somewhat LImited SCLC"??? - Discussion - Lung Cancer Survivors ... By lmgregory; Posted today at 6:13 pm · 0 replies; In Small cell lung cancer - General; Shared with the public. 0 Recommendations ... www.inspire.com/groups/lung-cancer.../somewhat-limited-sclc... | ||
| BMC Medical Genomics Generation of a non-small cell lung cancer transcriptome microarray. Austin Tanney*1, Gavin R Oliver1, Vadim Farztdinov1, Richard D Kennedy1, ... www.springerlink.com/index/M745081H2W848J36.pdf | ||
| CytRx initiates Phase IIb non-small-cell lung cancer trial Pharmacy Choice | (Datamonitor via COMTEX) CytRx Corporation, a biopharmaceutical company, has initiated a multicenter Phase IIb clinical trial with its ... www.bioportfolio.com/.../Cytrx-Initiates-Phase-Iib-Non-small-... | ||
| Discovery Could Lead to Breakthrough for Non-Small Cell Lung ... Research at Virginia Commonwealth University Massey Cancer Center led by Charles E. Chalfant, Ph.D., associate professor of biochemistry and molecular ... organizedwisdom.com/discovery-could-lead-to.../med | ||
| CytRx Initiating Phase 2b Clinical Trial with Tamibarotene in ... In the event that tamibarotene shows a substantial extension of life for sufferers of non-small-cell lung cancer, it would present a multi-billion dollar ... www.marketwatch.com/.../cytrx-initiating-phase-2b-clinical-tri... |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment